GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

Adaptive support ventilation: State of the art review.

Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.

Pubmed Full article

Doi:

Indian J Crit Care Med

Factor de impacto:

Doi:

Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes

Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas

Pubmed Full article

Doi:

PLoS ONE

Factor de impacto:

Q2

Doi:

Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.

Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin

Pubmed Full article

Doi:

J. Infect Dis

Factor de impacto:

Q1

Doi:

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott

Pubmed Full article

Doi:

Vaccine

Factor de impacto:

Q2

Doi:

Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthyinfants and toddlers in Spain

Javier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, Francisco Gimenez-Sanchez, Federico Martinon-Torres, Valentin Pineda-Solas, Alfonso Delgado, Pilar Infante-Marquez, John Z. Liang, Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott

Pubmed Full article

Doi:

Vaccine

Factor de impacto:

Q2

Doi:

THE NEVER ENDING STORY OF CORTICOSTEROIDS IN ACUTE BRONCHIOLITIS

Martinón-Torres F, Montero-Martín M.

Pubmed Full article

Doi:

Pediatrics

Factor de impacto:

Q1

Doi:

Noninvasive ventilation with helium-oxygen in children

Federico Martinón Torres

Pubmed Full article

Doi:

J. Crit Care

Factor de impacto:

Q3

Doi:

Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin

Gabriela Rüger, Giovanni Gabutti, Hans Rümke, Lars Rombo, Enrique Bernaola, MD,|| Javier Diez-Domingo, Federico Martinon-Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin and Martine Baudin,

Pubmed Full article

Doi:

Pediatr Infect Dis J.

Factor de impacto:

Q1

Doi:

A reverse evidence of rotavirus vaccines impact.

Federico Martinón-Torres, Angela Aramburo, Nazareth Martinón-Torres, Miriam Cebey, María Teresa Seoane-Pillado, Lorenzo Redondo-Collazo and Jose Maria Martinón-Sánchez

Pubmed Full article

Doi:

Human Vaccines & Immunother

Factor de impacto:

Q2

Doi:

Management of acute bronchiolitis in emergency wards in Spain: variability and appropriateness analysis (Abreviado project)

Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project (Bronchiolitis--Study of Variability, Adequacy, and Adherence) (Martinón –Torres F).

Pubmed Full article

Doi:

European J of Ped.

Factor de impacto:

Q2

Doi:

A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION

J.Gómez-Rial, F.Martinón-Torres

Clin Immunol

Factor de impacto:

Q2

Doi:

Pubmed Full article

MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS

Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas

bioRxiv

Factor de impacto:

Q1

Doi:

Pubmed Full article

CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2

Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)

JAMA

Factor de impacto:

Q1

Doi:

Pubmed Full article

RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS

Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas

International J Molecular Sciences

Factor de impacto:

Q1

Doi:

Pubmed Full article

COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.

Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.

Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.

Martinón-Torres F, Serra L, Safadi MAP.

Expert Rev Vaccines

Factor de impacto:

Q2

Doi:

Pubmed Full article

PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.

Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

Pubmed Full article

WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY

Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study

Clin Infect Dis

Factor de impacto:

Q1

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics